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Abstract
Background: Preoperative left ventricular dysfunction is an established risk factor for early and late mortality after 
revascularization. This retrospective analysis demonstrates the effects of preoperative ejection fraction on the short-
term and long-term survival of patients after coronary artery bypass grafting.
Methods: Early and late mortality were determined retrospectively in 10 626 consecutive patients who underwent 
isolated coronary bypass between January 1998 and December 2007. The subjects were divided into 3 groups 
according to their preoperative ejection fraction. Expected survival was estimated by comparison with a general Dutch 
population group described in the database of the Dutch Central Bureau for Statistics. For each of our groups with a 
known preoperative ejection fraction, a general Dutch population group was matched for age, sex, and year of 
operation.
Results and Discussion: One hundred twenty-two patients were lost to follow-up. In 219 patients, the preoperative 
ejection fraction could not be retrieved. In the remaining patients (n = 10 285), the results of multivariate logistic 
regression and Cox regression analysis identified the ejection fraction as a predictor of early and late mortality. When 
we compared long-term survival and expected survival, we found a relatively poorer outcome in all subjects with an 
ejection fraction of < 50%. In subjects with a preoperative ejection fraction of > 50%, long-term survival exceeded 
expected survival.
Conclusions: The severity of left ventricular dysfunction was associated with poor survival. Compared with the survival 
of the matched general population, our coronary bypass patients had a worse outcome only if their preoperative 
ejection fraction was < 50%.
Introduction
Despite improvement in medical therapies and surgical
techniques, the management of patients with coronary
artery disease and a low ejection fraction (EF) remains
challenging. In patients with a low EF, coronary artery
bypass grafting (CABG) has been shown to be superior to
medical therapy alone, to produce a statistically signifi-
cant clinical improvement, and to improve long-term
survival [1-5]. In such patients, however, CABG is associ-
ated with higher postoperative morbidity and mortality
rates than those in patients whose left ventricular func-
tion is within normal limits [5,6]. In an earlier investiga-
tion [7], we showed that superior long-term results after
CABG occurred in a group of patients with a low EF (<
40%) who were prospectively studied. However, most
such reports are limited by inadequate sample size. In this
study of patients who underwent CABG, we correlated
risk factors and outcomes with preoperative EF and com-
pared the long-term survival of our subjects with that of
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matched cohorts from the general population of The
Netherlands.
Methods
This retrospective study consisted of 10 626 patients who
underwent isolated CABG performed in the Department
of Cardiothoracic Surgery at Catharina Hospital in Eind-
hoven, The Netherlands, between January 1998 and
December 2007. After excluding 122 patients who were
lost to follow-up and 219 patients whose the preoperative
EF was not retrieved, 10285 patients were evaluated. The
study was performed after permission from the local
medical ethics committee had been received.
Preoperative EF
The global EF was determined with 1 or both of following
methods: calculation with 2-dimensional echocardiogra-
phy via the biplane apical method and the modified
Simpson's rule [8], and/or ventriculographic evaluation
performed by an independent surgeon and an indepen-
dent cardiologist. The patients were divided into 3 groups
as follows: group 1, EF > 50% (n = 8204); group 2, EF =
35% to 50% (n = 1717); group 3, EF < 35% (n = 364).
Operative techniques
All patients received short-acting anesthetic drugs to
facilitate early extubation. Extracorporeal circulation was
performed via a normothermic nonpulsatile flow. Cold
crystalloid cardioplegia ("St. Thomas solution") or warm-
blood cardioplegia was used according to the surgeon's
preference to induce and maintain cardioplegic arrest.
Follow-Up
Follow-up data on mortality were gathered from the data-
bases of health insurance companies, general practitio-
ners, and (if necessary) the governmental authorities.
Early mortality was defined as death that occurred from
any cause within the first 30 postoperative days, and late
mortality was defined as death that occurred more than
30 days after surgery, regardless of cause. For calculating
survival of a general population cohort, data were
obtained from the Dutch Central Bureau for Statistics
(CBS). This is the database registering information about
all citizens living in the Netherlands. Every year, a report
from the CBS is available online about mortality within
the normal population stratified by age and sex. We have
matched each group in our study with the general popu-
lation according to age and sex. Because the incidence of
mortality within the general population varies per year,
the matching was also done to compare the survival of
each group with the survival of the general population for
the same year when the studied patients were operated.
We considered the survival of the matched general popu-
lation cohort to represent the expected survival of the
patient group.
Statistical analyses
Discrete variables, which were compared by means of the
chi-squared test, are presented as numbers and percent-
ages. Continuous variables were compared by means of
the t test and analysis of variance and are presented as the
mean ± standard deviation. Univariate and multivariate
logistic regression analyses were performed to investigate
the impact of biomedical variables on early mortality.
Univariate analyses were used to test potentially con-
founding effects of biomedical and demographic factors
on outcome. The Cox proportional hazard regression
analysis was performed to evaluate late mortality. If the P
value decreased to < .05, then confounding variables were
included in the multivariate logistic and Cox regression
analyses. Long-term survival was depicted with the
Kaplan-Meier method. For comparisons of long-term
survival, we used log-rank statistics. "Time zero" was used
to designate the time of CABG. The results of timetable
analyses were used to describe 5-year and 10-year sur-
vival, and comparisons were made with the Wilcoxon
test. For all tests, a P value of < .05 indicated statistical
significance. Hazard ratios are reported with 95% confi-
dence intervals. All statistical analyses were performed
with SPSS software (Statistical Product and Service Solu-
tions, version 15.0, SSPS Inc, Chicago, Illinois).
Results
The minimum follow-up interval for surviving patients
was 60 days. The mean follow-up period was 1696 ± 1026
days (range, zero to 3708 days; day zero represented oper-
ative death).
The baseline characteristics of patients in the various
EF groups are represented in Table 1. Table 2 shows the
operative details of patients in those EF groups. Patients
with a low EF (groups 2 and 3) had a longer extracorpo-
real circulation time than did the other subjects and were
more likely to require perioperative intra-aortic balloon
pump support than were patients whose EF was within
normal limits. There were also fewer off-pump opera-
tions in patients with a low EF.
Early and late mortality were statistically significantly
higher in patients with a lower EF (Table 3). Risk factors
for early mortality identified by univariate and multivari-
ate logistic regression analyses are shown in Table 4. Uni-
variate logistic regression analysis identified preoperative
EF as a risk factor for early mortality. However, the haz-
ard ratio was higher in patients with an EF of < 35% than
in those with an EF of 35% to 50%. Other risk factors
identified by univariate analysis included age, New York
Heart Association class, diabetes, chronic obstructive
pulmonary disease (COPD), peripheral vascular disease
(PVD), anemia, renal dysfunction, prior cardiac surgery,
and emergency operation. Perioperative complications
such as myocardial infarction, the need for intra-aorticSoliman Hamad et al. Journal of Cardiothoracic Surgery 2010, 5:29
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balloon pump support, and re-exploration were also
identified as risk factors for early mortality.
All preoperative risk factors identified by univariate
analysis were entered in the multivariate logistic regres-
sion model. A low EF proved to be an independent risk
factor for early mortality. Other factors were age, diabe-
tes, COPD, renal dysfunction, prior cardiac surgery, and
emergency operation.
The results of Cox regression analysis to identify risk
factors for late mortality are shown in Table 5. Univariate
analysis identified preoperative EF as a risk factor for late
mortality. Other significant risk factors were age, sex,
New York Heart Association class, hypertension, anemia,
COPD, diabetes, renal dysfunction, PVD, and prior car-
diac surgery. When those factors were entered into the
multivariate analysis, a low EF proved to be an indepen-
Table 1: Preoperative characteristics of the study subjects*.
Variables Group 1
(EF > 50%)
(n = 8204)
Group 2
(EF = 35% -50%)
(n = 1717)
Group 3
(EF < 35%)
(n = 364)
P Value
Age (y) (mean ± SD) 64.5 ± 9.5 65.0 ± 9.7 65.6 ± 8.9 0.014
Male sex (%) 6254 (76.2) 1382 (80.5) 297 (81.6) < 0.0001
NYHA class III or IV (%) 436 (5.3) 142 (8.3) 53 (14.6) < 0.0001
Angina class (mean ± SD) 2.7 ± 1.2 2.6 ± .3 2.3 ± 1.5 0.012
Hypertension (%) 3554 (43.3) 649 (37.8) 127 (34.9) < 0.0001
COPD (%) 987 (12.0) 258 (15.0) 58 (15.9) < .0001
Diabetes (%) 1692 (20.6) 413 (24.1) 96 (26.4) < 0.0001
1 Prior MI (%) 2635 (32.3) 1016 (59.3) 204 (56.0) < 0.0001
2 Prior MIs (%) 280 (3.4) 167 (9.7) 55 (15.1) < 0.0001
> 2 Prior MIs (%) 25 (0.3) 15 (0.9) 6 (1.6) < 0.0001
CrCl < 60 mL/min (%) 2168 (27.4) 568 (34.4) 152 (44.4) < 0.0001
PVD (%) 908 (11.1) 239 (13.9) 51 (14.0) 0.002
Emergency (%) 237 (2.9) 71 (4.1) 33 (9.1) < 0.0001
Prior cardiac surgery (%) 384 (4.7) 154 (9.0) 39 (10.7) < 0.0001
EF = Ejection fraction, NYHA = New York Heart Association, COPD = chronic obstructive pulmonary disease, MI = myocardial infarction, CrCl 
= creatinine clearance, PVD = peripheral vascular disease.
*Data are represented as number (percent) or as the mean ± SD.
Table 2: Operative details of the study subjects*.
Variables Group 1
(EF > 50%)
(n = 8204)
Group 2
(EF = 35% -50%)
(n = 1717)
Group 3
(EF < 35%)
(n = 364)
P Value
Off-pump (%) 780 (9.5) 101 (5.9) 21 (5.8) < 0.0001
IMA (%) 7378 (89.9) 1494 (87.0) 277 (76.1) < 0.0001
No. anastomoses (mean ± SD) 3.42 ± 1.1 3.5 ± 1.1 3.62 ± 1.1 0.295
Cardioplegia:
Crystalloid (%) 2432 (36.4) 479 (38.1) 118 (42.0) < 0.001
Blood (%) 3299 (49.35) 652 (51.9) 133 (47.3) < 0.001
ECC time (min) (mean ± SD) 56.5 ± 32.7 61.9 ± 31.0 68.0 ± 35.8 < 0.001
Re-exploration (%) 428 (5.2) 119 (6.9) 13(3.6) 0.009
Perioperative MI (%) 240 (2.9) 49 (2.9) 12 (3.3) 0.775
IABP (%) 121 (1.5) 56 (3.3) 30 (8.2) < 0.0001
EF = Ejection fraction, IMA = internal mammary artery, ECC = extracorporeal circulation, MI = myocardial infarction, IABP = intra-aortic balloon 
pump support.
*Data are represented as the number (%) or mean ± SD.Soliman Hamad et al. Journal of Cardiothoracic Surgery 2010, 5:29
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dent risk factor for late mortality. Other statistically sig-
nificant factors were age, sex, New York Heart
Association class, diabetes, COPD, renal dysfunction,
anemia, PVD, and prior cardiac surgery.
Figure 1 shows long-term survival stratified by preop-
erative EF. The log-rank test yielded a P value of < .0001,
which indicates statistically significant differences in
long-term survival among all groups. Patients in group 1
(EF > 50%) had greater long-term survival than that
expected (P < .0001). However, the long-term survival of
patients in both group 2 (EF = 35-50%) and group 3 (EF <
35%) was worse than the expected survival (P < .0001;
log-rank test). One-year, 5-year and 10-year survival dif-
fered among patient groups (Wilcoxon test P  value <
.0001) (Table 6).
Discussion
The main finding of this study was that preoperative EF is
a statistically significant predictor for higher rates of early
and late mortality after CABG. Patients with a low EF had
Table 3: Early and late mortality according to preoperative ejection fraction.
Variables Group 1
(EF > 50%)
(n = 8204)
Group 2
(EF = 35% -50%)
(n = 1717)
Group 3
(EF < 35%)
(n = 364)
P Value
Early mortality (%) 129 (1.6) 63 (3.7) 38 (10.5) < .0001
Late mortality (%) 742 (9.1) 296 (17.4) 81 (22.4) < .0001
EF = Ejection fraction.
Table 4: Univariate and multivariate logistic regression analyses of risk factors for early mortality in the study subjects†.
Risk factors OR early mortality
Univariate analysis
P value OR early mortality
Multivariate analysis
P value
EF 35% - 50% 2.623 (1.923 -3.578) < .0001 1.9 (1.335 -12.693) < .0001
EF < 35% 7.592 (5.143 -11.207) < .0001 4.206 (2.6 -6.805) < .0001
Age (y)* 1.08 (1.062 -1.098) < .0001 1.031 (1.004 -1.059) .026
Male sex 0.802 (0.601 -1.070) .071
NYHA class 1.338 (1.122 -1.595) .001 1.168 (0.908 -1.503) .227
Angina class 1.002 (0.951 -1.055) .277
Hypertension 0.929 (0.716 -1.207) .662
COPD 1.966 (1.438 -2.687) < .0001 1.479 (0.943 -2.319) .089
Preoperative Hb level 0.692 (0.634 -0.755) < .0001 0.883 (0.779 -1.001 .051
Diabetes 1.524 (1.148 -2.023) .004 1.743 (1.195 -2.543) .004
Preoperative CrCl 0.965 (0.962 -0.968) < .0001 0.978 (0.967 -0.988) < .0001
PVD 1.633 (1.164 -2.290) .005 1.441 (991 -2.277) .118
Prior cardiac surgery 4.542 (3.304 -6.244) < .0001 3.064 (1.847 -5.083) < .0001
No. of anastomoses 0.903 (0.801-1.011) .077
Off-pump 0.631 (0.366 -1.087) .097
Use of IMA 0.231 (0.176 -0.303) < .001
Cardioplegia 1.312 (0.995 -1.731) .054
Emergency 6.550 (4.722 -9.087) < .0001 3.307 (1.597 -6.846) .001
Perioperative MI 5.938 (4.053 -8.699) < .0001
Re-exploration 5.810 (4.261-7.922) < .0001
IABP 13.974 (9.916 -19.691) < .0001
OR = Odds ratio, EF = ejection fraction, NYHA = New York Heart Association, COPD = chronic obstructive pulmonary disease, Hb = 
hemoglobin, CrCl = creatinine clearance, PVD = peripheral vascular disease, IMA = internal mammary artery, MI = myocardial infarction, IABP 
= intra-aortic balloon pump support.
† Only preoperative variables which are significant in the univariate analysis were entered into the multivariate analysis
*Entered as a continuous variable.Soliman Hamad et al. Journal of Cardiothoracic Surgery 2010, 5:29
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a worse survival than did patients whose EF was within
normal limits. Revascularization in patients with a low EF
has been reported by several authors to be superior to
medical therapy. Alderman and colleagues [1] showed
that patients with an EF of ≤ 35% who were treated with
medical management had a 43% 5-year survival rate as
opposed to a 63% 5-year survival rate in the surgically
treated patients. Although CABG enables longer survival
and a better quality of life than does medical therapy, the
p o s t s u r g i c a l  o u t c o m e s  o f  p a t i e n t s  w i t h  a  l o w  E F  h a v e
been shown to be considerably worse than those in
patients with a high EF [3,6].
A low EF has been shown to be an independent risk fac-
tor for high operative mortality [9,10]. In our study, we
noted that the early mortality rate in patients with an EF
of < 35% was more than 6 times higher than that in
patients with an EF of > 50% (10.5% vs 1.6%). This finding
supports the results of other studies on the initial effect of
isolated CABG on mortality in patients with a low EF. Di
Carli and colleagues [4] reported a 9.3% 30-day mortality
rate in patients with an EF of < 40%. Christakis and col-
leagues [6] demonstrated a 9.8% operative mortality rate
in patients with an EF of < 20%, and a study by Carr and
colleagues [11] demonstrated an 11% perioperative mor-
tality rate in patients with an EF between 10% and 20%.
However, more recent reports have shown lower opera-
tive mortality rates. In a review of the New Y ork State
database [12], the early mortality rate of patients with an
EF of ≤ 20% was 4.6%. Another report showed an in-hos-
pital mortality rate of 4% in patients with an EF of < 30%
[13]. In an earlier report, we found approximately the
same in-hospital mortality rate (4%) in 75 prospectively
studied patients with an EF of < 40% [14]. The decline of
those mortality rates over time showed a statistically sig-
nificant improvement from the double-digit rates
reported in the 1980s. We suggest that improvements in
cardiac anesthesia, perioperative care, surgical tech-
niques, emergency cardiac care, and postoperative man-
agement contribute significantly to more encouraging
outcomes.
Table 5: Univariate and multivariate Cox regression analyses of risk factors for late mortality†.
Risk factor HR late mortality
Univariate analysis
P value HR late mortality
Multivariate analysis
P value
EF 35% -50% 1.866 (1.614 -2.157) < .0001 1.562 (1.339 -1.822) < .0001
EF < 35% 2.859 (2.231-3.665) < .0001 1.051 (0.924 -1.196) < .0001
Age (y)* 1.094 (1.086 -1.103) < .0001 1.067 (1.053 -1.081) < .0001
Male sex 0.835 (0.726 -0.961) .012 1.629 (1.346 -1.97) < .0001
NYHA class 1.201 (1.094 -1.318) < .0001 1.501 (1.267 -1.779) < .0001
Angina class 1.002 (0.951-1.055) .95
Hypertension 1.223 (1.079 -1386) .002 1.137 (0.971 -1.33) .11
COPD 1.778 (1.523 -2.077) < .0001 1.473 (1.211 -1.792) < .0001
Diabetes 1.733 (1.512 -1.985) < .0001 1.526 (1.287 -1.809) < .0001
Preoperative CrCl 0.965 (0962 -0.968) < .0001 0.986 (0.981 -0.992) < .0001
PVD 2.307 (1.978 -2.690) < .0001 1.699 (1.397 -2.066) < .0001
Preoperative Hb 0.743 (0.711 -0.777) < .0001 0.867 (0.816 -0.922) < .0001
Prior cardiac surgery 1.536 (1.248 -1.891) < .0001 1.143 (0.851-1.536) .374
Emergency 1.268 (0.957 -1.681) .099
No. of anastomoses 1.089 (1.032 -1.148) .002
Use of IMA 0.544 (0.465 -0.637) < .0001
Off-pump 0.76 (0.58 -0.996) .046
Perioperative MI 1.801 (1.331-2.437) < .0001
Re-exploration 1.673 (1.344 -2.082) < .0001
IABP 1.903 (1.364 -2.655) < .0001
HR = Hazard ratio, EF = ejection fraction, NYHA = New York Heart Association, COPD = chronic obstructive pulmonary disease, CrCl = 
creatinine clearance, PVD = peripheral vascular disease, Hb = hemoglobin, IMA = internal mammary artery, MI = myocardial infarction, IABP 
= intra-aortic balloon pump support.
† Only preoperative variables which are significant in the univariate analysis were entered into the multivariate analysis
*Entered as a continuous variable.Soliman Hamad et al. Journal of Cardiothoracic Surgery 2010, 5:29
http://www.cardiothoracicsurgery.org/content/5/1/29
Page 6 of 8
Patients with impaired left ventricular function who
undergo CABG are a distinctive group of patients. Their
risk factors that increase the postoperative mortality rate
may not be similar to risk factors usually found in
patients whose EF is within normal limits. Christakis and
colleagues [6] observed that the urgency of surgery was
the only independent predictor of operative mortality in
p a t i e n t s  w i t h  a n  E F  o f  <  2 0 %  w h o  u n d e rw e n t  C A BG .
Other authors [15] have reported that an age of > 70 years
was the only independent predictor of in-hospital mortal-
i t y  i n  p a t i e n t s  w i t h  a n  E F  o f  ≤  3 0 %  w h o  u n d e r w e n t
CABG. Hausmann and colleagues [16] noted that
increased left ventricular end diastolic pressures,
decreased cardiac index, and New York Heart Associa-
tion class were univariate predictors of operative mortal-
i t y  i n  p a t i e n t s  w i t h  a n  E F  o f  <  3 0 % .  A r g e n z i a n o  a n d
colleagues [17] found that reoperation and congestive
heart failure were predictors of perioperative mortality in
patients with an EF of ≤ 35%. In our study, patients with a
low EF had a higher incidence of preoperative comorbid
conditions such as diabetes, New York Heart Association
class III or IV, COPD, renal dysfunction, PVD, and/or
reoperation than did those with normal EF. Those factors
may have contributed to the higher incidence of early
mortality in patients with low EF. Using multivariate
logistic regression analysis, we found age, New York
Heart Association class, renal dysfunction, COPD, diabe-
tes, reoperation, and emergency operation to be statisti-
cally significant predictors of in-hospital mortality.
The results of our study confirmed that patients with a
lower EF have a poorer long-term outcome than do
patients whose EF is within normal limits. We found that
in patients with an EF of < 35%, the 5-year survival rate
was 64.8%, and the 10-year survival rate was 44.7%. Those
statistics compare favorably with the results of medical
treatment, even in the current era of aggressive use of
angiotensin-converting enzyme inhibitors and other
medications for congestive heart failure [18]. In some
studies, complete revascularization of the ischemic myo-
cardium had a major impact on long-term survival, even
when viability was not consistently documented. Shapira
and colleagues [19] noted a 5-year survival of 76% in
patients with an EF of < 30% who underwent CABG. Sim-
ilar results were reported by other investigators [9,20-23].
The number of studies addressing 10-year survival in
such patients, however, is limited. In a study by Shah and
colleagues [20], the 5-year survival rate in patients with
an EF of < 35% was 55%, and the 10-year survival rate was
23.9%. In a recent study of patients with an EF of ≤ 30,
approximately 80% were alive 5 years after surgery, and
45% were alive 10 years after surgery [24]. A 20-year sur-
vival study by Weintraub and colleagues showed that a
low EF independently predicted poor long-term survival
after CABG, although the subjects experienced good
relief from angina [25].
Like other authors [20,21], we observed that age and
male sex are independent predictors of long-term out-
come in patients undergoing CABG. Other important
predictors were New York Heart Association class,
COPD, anemia, renal dysfunction, diabetes, and PVD.
Bouchart and colleagues [10] identified the following sta-
tistically significant predictors of long-term survival after
CABG in patients with an EF of ≤ 20%: a chief complaint
of only pain, unstable angina, and a Canadian and New
York Heart Association class lower than IV.
Case selection has been shown to be an important fac-
tor in achieving a favorable outcome after CABG in
patients with a low EF [24]. Our study included patients
without preoperative viability test results and those with
Figure 1 Kaplan-Meier curve of study groups and their expected 
survival.
Table 6: Survival rates (%) for 1, 5, and 10 years, stratified by preoperative ejection fraction (EF).
1-year 5-year 10-year
Group 1 (EF > 50%) 95.1 ± 0.2 87.9 ± 0.4 78.6 ± 0.9
Group 2 (EF = 35-50%) 90.0 ± 0.8 78.9 ± 0.12 50.7 ± 6.8
Group 3 (EF < 35%) 79.0 ± 2.2 64.8 ± 2.9 44.7 ± 6.5Soliman Hamad et al. Journal of Cardiothoracic Surgery 2010, 5:29
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a ventricular aneurysm or associated mild or moderate
mitral regurgitation. Di Carli and colleagues [4] showed
that in patients evaluated with positron emission tomog-
raphy, those who had an EF of < 40% and a viable myocar-
dium had a better 4-year survival rate than did patients
without evidence of a viable myocardium.
A rather unique feature of our study is that we com-
pared the survival of our patients with that of a cohort of
the general Dutch population matched for age, sex, and
year of operation. Over the years, variation in life expec-
tancy and mortality rates of the Dutch population has
been well documented by the Dutch Central Bureau for
Statistics. We used data from the Central Bureau for Sta-
tistics to compare survival of our patients with the sur-
vival of general population cohorts matched for age and
sex (expected survival). We found that patients with a low
EF had worse long-term survival than that their matched
cohort of the Dutch citizens. Patients whose EF was
within normal limits had better long-term survival than
that in the matched cohort of the general Dutch popula-
tion. Although that information does not guide surgical
decision making, it may be relevant for patients with
regard to their long-term prognosis. Nevertheless, those
findings must be interpreted with caution, because the
Dutch Central Bureau for Statistics database includes
data from the entire Dutch population. As a result, data
from the patients described in this study as well as data
from patients treated in other cardiac surgery centers are
included. In patients who underwent CABG, the protec-
tion provided by revascularization, the postoperative
medical therapy administered to treat hypertension and
hypercholesterolemia, and the use of antiplatelet therapy
may increase the bias. In addition, patients who are
scheduled to undergo CABG receive preoperative screen-
ing for, and treatment of underlying diseases that may
contraindicate surgery. Perhaps for those reasons, sur-
vival in patients whose EF was within normal limits was
longer than the expected survival in the matched cohort
of the normal general population.
Limitations of the study
Like most similar reports, our study was based on the ret-
rospective evaluation of patient charts. To prove the use-
fulness of a surgical procedure, a study must be
prospective, controlled, and randomized. However, we
suggest that the relatively large number of patients in our
report justifies our conclusions. The primary endpoint of
the study was all-cause mortality. We were not able to
retrieve the cause of death in both groups which could be
equally important. Information about the quality of life of
the surviving patients, their eventual symptoms, and their
incidence of rehospitalization; residual mitral regurgita-
tion; the recurrence of congestive heart failure; and other
possible complications is lacking. W e recommend cau-
tion in interpreting the results of the comparison with the
general population. The Central Bureau for Statistics
database includes the total Dutch population. Therefore,
data of the patients described in this study and of those
treated at other Dutch cardiac surgery centers are also
included in the CBS databse. Because of this, the magni-
tude of differences between groups tends to be lessened.
The annual number of patients undergoing CABG in the
Netherlands is small, (10 000 patients), compared to the
total number of the general population, limiting the effect
of this inaccuracy. Clinical information including data
about the EF is missing in the general population group.
However, the results of our study can help in informing
patients with normal preoperative EF that their prognosis
after CABG is favourable.
Conclusions
This study confirmed that a low EF is a predictive risk
factor for early and late mortality after CABG. Patients
whose EF was within normal limits (ie, > 50%) had better
long-term survival than that in a matched cohort of the
general Dutch population, but patients with a low EF (ie,
< 50%) had a worse long-term survival than that in their
respective matched cohort.
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